---
Domain: "06"
Subdomain:
  - Opthalmology
Date: 2024-04-08
tags: [Occular-drugs]
Date modified: Friday, October 4th 2024, 4:59:55 pm
---

# Systemic and Ocular Effects of Ophthalmic Drugs

## Introduction
- **Ophthalmic Surgery Requirements**:
  - Immobile patient
  - Akinesia
  - Normal (16 ± 5 mmHg) or low intra-ocular pressure (IOP)
  - Analgesia
- **Adverse Anaesthetic Practice**:
  - Can cause a rise in IOP, potentially leading to permanent eye damage, particularly in intra-ocular procedures and perforating eye injuries.
  - Sudden decompression and prolapse of the lens, iris, or vitreous can occur through the surgical incision or perforation.
- **Intra-Ocular Pressure (IOP)**:
  - Tension exerted by the contents of the eye on the scleral envelope.
  - Main determinants:
	- Dynamic equilibrium of aqueous humour production and drainage.
	- Intra-ocular blood volume.
	- Scleral capacity and rigidity, including extra-ocular muscle tone.
- **Systemic Effects of Topical Ophthalmic Drugs**:
  - Many topical ophthalmic drugs may have systemic effects that are significant to anaesthetists and patient safety.

## Effects of Anaesthetic Drugs on the Eye

### Effect of Drugs on Intra-Ocular Pressure

**Decrease IOP**:
- **Opioids**: alfentanil, fentanyl, morphine, remifentanil, sufentanil
- **Induction agents**: thiopental, propofol, etomidate
- **Inhalational agents**: halothane, enflurane, isoflurane, sevoflurane, desflurane
- **Muscle relaxants**: vecuronium, rocuronium, pancuronium
- **Benzodiazepines**: diazepam i.v.
- **Miscellaneous**: lidocaine i.v., nifedipine s.l.

**Increase IOP**:
- **Induction agents**: ketamine
- **Muscle relaxants**: succinylcholine
- **Miscellaneous**: metoclopramide

**No Change in IOP**:
- **Benzodiazepines**: oral preparations, midazolam i.v.
- **Anticholinergics**
- **Muscle relaxants**: atracurium
- **Miscellaneous**: nitrous oxide, anticholinesterases (neostigmine)

### Premedication
- **Benzodiazepines**:
  - Sedative and muscle-relaxing properties.
  - Oral preparations: no fall in IOP, may attenuate rise in IOP with laryngoscopy and intubation.
  - IV diazepam: temporary fall in IOP (<10 min).
  - IV midazolam: no effect on IOP.
- **Anticholinergics**:
  - Little effect on IOP when given IM or IV before surgery.
- **Anti-emetics**:
  - Reduces PONV and subsequent rise in central venous pressure.
  - Metoclopramide (IV): small rise in IOP (30 min).
  - Ondansetron: no effect on IOP, preferred in perforating eye injuries.

### Induction Agents
- **IV Induction Agents**:
  - All lower IOP except ketamine.
  - Ketamine: increases IOP (systemic blood pressure, choroidal blood volume, extra-ocular muscle contraction).
  - Thiopental, propofol, etomidate: reduce IOP (propofol causes greatest fall).

### Maintenance of Anaesthesia
- **Nitrous Oxide**:
  - No direct effect on IOP.
  - Avoid in retinal detachment procedures with intravitreal gas injections (air, sulphur hexafluoride).
- **Volatile Anaesthetic Agents**:
  - Halothane, enflurane, isoflurane, sevoflurane, desflurane: reduce IOP dose-dependently.
  - Sevoflurane: decreased IOP despite reduced intra-ocular compliance, preferred in children (fewer dysrhythmias and bradycardia).
  - Avoid agents causing airway irritation (coughing increases IOP).

### Neuromuscular Blocking Agents
- **Succinylcholine**:
  - Ideal for intubation, increases IOP (8-10 mmHg for 5-10 min).
  - Debate on use in open globe injuries; balance risk of eye damage vs. aspiration prevention.
- **Non-depolarising Muscle Relaxants**:
  - Reduce IOP due to extra-ocular muscle relaxation.
  - Rocuronium: alternative to succinylcholine, no IOP rise, but longer action.
  - Atracurium and vecuronium: reduce IOP, suitable for elderly, do not prevent IOP rise with intubation.

### Opioids
- **Prevent IOP Rise**:
  - Alfentanil (10-40 μg/kg), fentanyl (5 μg/kg), remifentanil (1 μg/kg).
  - Mechanisms: relaxing extra-ocular muscles, miosis, reducing arterial pressure.
  - Side effects: bradycardia, hypotension, nausea, vomiting (elderly).
- **Other Agents**:
  - **Nifedipine (10 mg sublingual)**: attenuates IOP rise due to succinylcholine and intubation.
  - **Lidocaine (2 mg/kg IV)**: suppresses IOP rise with intubation.

## Systemic Effects of Drugs Used in Ophthalmic Surgery

### Pharmacokinetics and Pharmacodynamics
- **Systemic Absorption**:
  - Occurs via conjunctival sac, nasal mucosa, gastrointestinal tract.
  - Slow diffusion into circulation via conjunctival capillaries.
  - Nasolacrimal duct absorption comparable to IV injection.
  - Finger pressure on inner canthus reduces absorption.
  - No first-pass metabolism, high plasma concentrations.
  - Increased absorption from hyperaemic/dry eyes or supine patients.
  - Children/elderly less tolerant to cardiovascular agents.

### Sympathomimetics
- **Phenylephrine, Epinephrine, Dipivefrine, Brimonidine, Apraclonidine**:
  - Used for pupillary dilation, glaucoma treatment.
  - Side effects: hypertension, arrhythmias, coronary vasospasm.
  - Caution in elderly, children, cardiovascular/cerebrovascular disease.
  - Avoid 10% phenylephrine pre-anaesthesia.

### Adrenoreceptor Blocking Drugs
- **β-blockers** (Timolol, Betaxolol, Carteolol, Levobunolol):
  - Reduce aqueous production.
  - Side effects: bronchospasm, bradycardia, hypotension, cardiac failure.
  - Avoid in asthma, heart failure, heart block.
  - Interactions with verapamil, calcium channel antagonists.

### Parasympatholytics
- **Mydriatics** (Atropine, Homatropine, Cyclopentolate, Tropicamide):
  - Systemic absorption causes anticholinergic symptoms.
  - Side effects: dry mouth, flushing, tachycardia, arrhythmia, confusion, ataxia, convulsions.
  - Shorter duration/less effects with tropicamide, homatropine.

### Parasympathomimetics
- **Pilocarpine, Carbachol, Acetylcholine**:
  - Used for intra-ocular hypertension, miosis.
  - Side effects: asthma exacerbation, bronchospasm, diaphoresis, nausea, bradycardia, hypotension.
  - Ecothiopate: discontinued, but available on a named-patient basis, causes cholinergic side effects.

### Local Anaesthetics
- **Cocaine**:
  - Used for dacryocystorhinostomy, systemic absorption can cause adverse effects.
  - Toxic dose: >20 mg, peak concentration at 15-60 min, detectable up to 6 h.
  - Side effects: confusion, apprehension, convulsions, hyperpyrexia, hypertension, tachycardia, arrhythmias.
  - Avoid in patients on monoamine oxidase inhibitors, tricyclic antidepressants.

### Corticosteroids
- **Prednisolone, Dexamethasone**:
  - Systemic absorption without clinically significant consequences.

### Miscellaneous Agents
- **Felypressin**:
  - Vasoconstrictor in prilocaine preparations, may cause hypertension.
- **Diuretics** (Acetazolamide, Dorzolamide, Brinzolamide):
  - Reduce aqueous humour formation.
  - Side effects: blood disorders, rashes, electrolyte disturbances, reduced effectiveness of oral hypoglycaemics.
  - Topical agents cause less systemic effects.
- **Chloramphenicol**:
  - Topical use can cause blood dyscrasias; monitor full blood count.

# Links
- [[Ophthalmology]]
- [[Paediatric ophthalmology]]
- [[Post operative vision loss (POVL)]]

---

---
**References:**

1. Jain, D. (2022). Ocular effects of systemic medications. Delhi Journal of Ophthalmology, 32(3). https://doi.org/10.7869/djo.754
2. Labétoulle, M., Frau, E., & Jeunne, C. L. (2005). Systemic adverse effects of topical ocular treatments. La Presse Médicale, 34(8), 589-595. https://doi.org/10.1016/s0755-4982(05)83987-9
**Summary or mindmap:**

-------------------------------------------------------------------------------------
---
**Copyright**
© 2022 Francois Uys. All Rights Reserved.